Literature DB >> 18421387

Highly effective receptors showing di- vs. monosaccharide preference.

Monika Mazik1, Arno C Buthe.   

Abstract

Receptors and , incorporating two heterocyclic recognition units as well as oxime- or hydroxymethyl-based hydrogen-bonding sites, were prepared, and their binding properties toward neutral sugars were determined. The design of these receptors was inspired by the binding motifs observed in the crystal structure of protein-carbohydrate complexes. The receptors and are able to recognize both mono- and disaccharides, with a strong preference for the disaccharides. Both hydrogen-bonding and interactions of the sugar CH's with the phenyl rings of the receptor contribute to the stabilisation of the receptor-sugar complexes. Molecular modeling calculations, synthesis and binding studies are described.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18421387     DOI: 10.1039/b719212f

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  3 in total

1.  Regiochemical Effects on the Carbohydrate Binding and Selectivity of Flexible Synthetic Carbohydrate Receptors with Indole and Quinoline Heterocyclic Groups.

Authors:  Khushabu Thakur; Milan A Shlain; Mateusz Marianski; Adam B Braunschweig
Journal:  European J Org Chem       Date:  2021-09-12

2.  Recognition properties of receptors consisting of imidazole and indole recognition units towards carbohydrates.

Authors:  Monika Mazik; André Hartmann
Journal:  Beilstein J Org Chem       Date:  2010-02-02       Impact factor: 2.883

3.  Anti-HIV-1 activity of a tripodal receptor that recognizes mannose oligomers.

Authors:  Eva Rivero-Buceta; Paula Carrero; Elena Casanova; Elisa G Doyagüez; Andrés Madrona; Ernesto Quesada; María Jesús Peréz-Pérez; Raquel Mateos; Laura Bravo; Leen Mathys; Sam Noppen; Evgeny Kiselev; Christophe Marchand; Yves Pommier; Sandra Liekens; Jan Balzarini; María José Camarasa; Ana San-Félix
Journal:  Eur J Med Chem       Date:  2015-10-21       Impact factor: 6.514

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.